Tag Archives: Neurology

Sanofi Ventures surpasses $1.4 billion with new capital to accelerate early-stage medical innovation

(IN BRIEF) Sanofi has boosted its venture capital arm, Sanofi Ventures, with a new $625 million multi-year commitment, raising the fund’s assets under management to more than $1.4 billion. Since 2012, Sanofi Ventures has invested over $800 million in more … Read the full press release

Sanofi Acquires Vigil Neuroscience to Advance VG-3927 Alzheimer’s Program and Expand Neurodegeneration Research

(IN BRIEF) Sanofi has finalized its takeover of Vigil Neuroscience for roughly $470 million, acquiring all outstanding shares at $8 each and issuing a $2-per-share CVR tied to VG-3927’s first commercial sale. This deal, following Sanofi’s June 2024 strategic investment, … Read the full press release

Merck Forms AI-Driven Drug Discovery Collaborations with BenevolentAI and Exscientia

(IN BRIEF) Merck, a prominent science and technology company, has announced strategic drug discovery collaborations with AI technology firms BenevolentAI and Exscientia. These partnerships aim to leverage AI-driven design and discovery capabilities to advance research efforts in key therapeutic areas, … Read the full press release

Deborah Dunsire to Retire as Lundbeck CEO, Charl van Zyl Named Successor

(IN BRIEF) H. Lundbeck A/S has announced the initiation of CEO succession, with Deborah Dunsire choosing to retire from her role as President and CEO. Charl van Zyl has been appointed as the new President and CEO, and Dunsire will … Read the full press release

University of Liverpool leads new global project on understanding the effects of COVID-19 on the brain

(PRESS RELEASE) LIVERPOOL, 16-Oct-2020 — /EuropaWire/ — A new global project has been established to better understand how and why COVID-19 affects the brain. The COVID-Neuro Global programme, led by the University of Liverpool in cooperation with five leading research … Read the full press release